Wells Fargo’s Blonder Tongue Laboratories Inc BDR Stock Holding History

Wells Fargo’s Portfolio BDR Stock Details BDR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-37	Closed	–	–	7974
2022 Q1	$0	Buy	37 +1	+3%	+$1	﹤0.01%	8291
2021 Q4	$0	Buy	36 +2	+6%	+$2	﹤0.01%	8200
2021 Q3	$0	Buy	34 +6	+21%	+$7	﹤0.01%	7844
2021 Q2	$0	Buy	28 +1	+4%	+$1	﹤0.01%	7784
2021 Q1	$0	Buy	27 +6	+29%	+$9	﹤0.01%	7675
2020 Q4	$0	Hold	21	–	–	﹤0.01%	7311
2020 Q3	$0	Buy	21 +1	+5%	+$1	﹤0.01%	7201
2020 Q2	$0	Hold	20	–	–	﹤0.01%	7091
2020 Q1	$0	Buy	+20	New	+$15	﹤0.01%	7096

Wells Fargo's BDR Position: Q2 2022 in Review

Wells Fargo sold out of Blonder Tongue Laboratories Inc (BDR) in Q2 2022, closing a stake of 37 shares.

Wells Fargo first reported a position in BDR in Q1 2020 and held it in 9 quarters. The position peaked at $0 in Q1 2022. 0 funds tracked by Wall St. Rank hold BDR as of Q2 2022.

Wells Fargo reported no remaining Blonder Tongue Laboratories Inc position as of Q2 2022 after selling out during the quarter.
Wells Fargo sold 37 Blonder Tongue Laboratories Inc shares in Q2 2022.
Wells Fargo first reported a position in Blonder Tongue Laboratories Inc in Q1 2020 and held it in 9 quarters.
Wells Fargo's Blonder Tongue Laboratories Inc position peaked at $0 in Q1 2022.
0 funds tracked by Wall St. Rank held Blonder Tongue Laboratories Inc as of Q2 2022.

Based on Wells Fargo's 13F filing for Q2 2022, filed 12 Aug 2022.